509073-62-5Relevant articles and documents
Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators
Li, Ridong,Ning, Xianling,He, Jianan,Lin, Zhiqiang,Su, Yue,Li, Runtao,Yin, Yuxin
, (2021)
Pyruvate kinase M2 isoform (PKM2) plays a key role in cancer progression through both metabolic and non-metabolic functions, thus it is recognized as a potential target for cancer diagnosis and treatment. In this study, we discovered a sulfonamide-dithiocarbamate compound 8a as a novel PKM2 activator from a random screening of an in-house compound library. Then, a series of lead compound 8a analogs were designed and synthesized for screening as potent PKM2 activators. Among them, compound 8b (AC50 = 0.136 μM) and 8k (AC50 = 0.056 μM) showed higher PKM2 activation activities than positive control NZT (AC50 = 0.228 μM), and they (IC50 50 > 10 μM). Especially, compound 8k inhibited the proliferation of multiple cancer cells, but showed little toxicity on normal cells. In addition, we found that compound 8k inhibit the colony formation of MCF7 cells. Western blot analysis demonstrated that 8k could reduce PKM2 nuclear localization and block the downstream signaling pathway of PKM2, resulting in suppression of tumor cell proliferation. Overall, compound 8k may be a promising candidate for further mechanistic investigation of PKM2 and cancer therapy.
Optimization and SAR research at the piperazine and phenyl rings of JNJ4796 as new anti-influenza A virus agents, part 1
Wang, Aoyu,Li, Yuhuan,Lv, Kai,Gao, Rongmei,Wang, Apeng,Yan, Haiyan,Qin, Xiaoyu,Xu, Shijie,Ma, Chao,Jiang, Jiandong,Wei, Zengquan,Zhang, Kai,Liu, Mingliang
supporting information, (2021/06/15)
JNJ4796, a small molecule fuse inhibitor targeting the conserved stem region of hemagglutinin, effectively neutralized a broad spectrum of group 1 influenza A virus (IAV), and protected mice against lethal and sublethal influenza challenge after oral admi
Aminodithioformate compound used as FAK inhibitor
-
Paragraph 0089-0091; 0110-0112, (2020/05/09)
A purpose of the invention is to provide an aminodithioformate compound serving as an FAK inhibitor, a pharmaceutical composition, a preparation method and applications thereof, wherein the compound has a structure represented by the following general formula (I).